Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias W Beckmann

Showing results (541-550 of 799) with videos related to

Pageof 80
Sort By:
Breast Cancer Research : BCR|October 24, 2020
Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trialAmelie de Gregorio, Lothar Häberle, Peter A Fasching, et al.
Cell|August 29, 2015
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous RetrovirusesKatherine B Chiappinelli, Pamela L Strissel, Alexis Desrichard, et al.
International Journal of Cancer|April 25, 2025
Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD?Christoph Schubart, Lars Tögel, Maria Giulia Carta, et al.
Breast Care (Basel, Switzerland)|November 12, 2015
14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German ExpertsChristian Jackisch, Nadia Harbeck, Jens Huober, et al.
Breast (Edinburgh, Scotland)|December 15, 2017
Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registryVolkmar Müller, Naiba Nabieva, Lothar Häberle, et al.
Breast Care (Basel, Switzerland)|June 29, 2018
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating LymphocytesFranziska Würfel, Ramona Erber, Hanna Huebner, et al.
Journal for Immunotherapy of Cancer|June 26, 2021
Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapyHannah Reimann, Andrew Nguyen, J Zachary Sanborn, et al.
International Journal of Molecular Sciences|August 12, 2022
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World SettingRamona Erber, Miriam Angeloni, Robert Stöhr, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|August 28, 2023
Multicenter evaluation of blood-based biomarkers for the detection of endometriosis and adenomyosis: A prospective non-interventional studyStefanie Burghaus, Predrag Drazic, Monika Wölfler, et al.
International Journal of Cancer|June 25, 2020
Association of genomic variants at the human leukocyte antigen locus with cervical cancer risk, HPV status and gene expression levelsDhanya Ramachandran, Peter Schürmann, Qianqian Mao, et al.
Pageof 80

Showing results (541-550 of 799) with videos related to

Sort By:
Pageof 80
Breast Cancer Research : BCR|October 24, 2020
Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trialAmelie de Gregorio, Lothar Häberle, Peter A Fasching, et al.
Cell|August 29, 2015
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous RetrovirusesKatherine B Chiappinelli, Pamela L Strissel, Alexis Desrichard, et al.
International Journal of Cancer|April 25, 2025
Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD?Christoph Schubart, Lars Tögel, Maria Giulia Carta, et al.
Breast Care (Basel, Switzerland)|November 12, 2015
14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German ExpertsChristian Jackisch, Nadia Harbeck, Jens Huober, et al.
Breast (Edinburgh, Scotland)|December 15, 2017
Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registryVolkmar Müller, Naiba Nabieva, Lothar Häberle, et al.
Breast Care (Basel, Switzerland)|June 29, 2018
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating LymphocytesFranziska Würfel, Ramona Erber, Hanna Huebner, et al.
Journal for Immunotherapy of Cancer|June 26, 2021
Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapyHannah Reimann, Andrew Nguyen, J Zachary Sanborn, et al.
International Journal of Molecular Sciences|August 12, 2022
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World SettingRamona Erber, Miriam Angeloni, Robert Stöhr, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|August 28, 2023
Multicenter evaluation of blood-based biomarkers for the detection of endometriosis and adenomyosis: A prospective non-interventional studyStefanie Burghaus, Predrag Drazic, Monika Wölfler, et al.
International Journal of Cancer|June 25, 2020
Association of genomic variants at the human leukocyte antigen locus with cervical cancer risk, HPV status and gene expression levelsDhanya Ramachandran, Peter Schürmann, Qianqian Mao, et al.
Pageof 80